Susquehanna International Group
AURA icon

Susquehanna International Group’s Aura Biosciences AURA Stock Holding History

Susquehanna International Group’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$646K Buy
+96,500
New +$554K ﹤0.01% 9010
2025
Q1 		– Sell
-24,300
Closed -$200K – 12440
2024
Q4 		$200K Sell
24,300
-9,500
-28% -$89.4K ﹤0.01% 10727
2024
Q3 		$301K Buy
+33,800
New +$290K ﹤0.01% 9596

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Susquehanna International Group's AURA Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Aura Biosciences (AURA) in Q1 2026: 27,483 shares worth $184K. The stake represents ﹤0.01% of the portfolio and ranks #11783 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in AURA as recently as Q2 2025.

Susquehanna International Group first reported a position in AURA in Q1 2023 and has held it in 7 quarters since. The position peaked at $336K in Q1 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Susquehanna International Group held 27,483 shares of Aura Biosciences worth $184K as of Q1 2026.
  • Aura Biosciences was a new Susquehanna International Group position in Q1 2026.
  • Aura Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11783 holding.
  • Susquehanna International Group first reported a position in Aura Biosciences in Q1 2023 and has held it in 7 quarters since.
  • Susquehanna International Group's Aura Biosciences position peaked at $336K in Q1 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.